Lv11
44 积分 2022-06-24 加入
CAR T cells secreting anti-EpCAM bispecific T cell engagers overcome tumor heterogeneity in targeting epithelial-originated carcinomas
6小时前
待确认
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
7个月前
已完结
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
7个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
7个月前
已完结
pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication
7个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
7个月前
已完结
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
8个月前
已完结
Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering
8个月前
已完结
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy
9个月前
已完结
T cell-engaging therapies — BiTEs and beyond
11个月前
已完结
皖公网安备34019202002308
